Skip to Content

Palforzia (peanut allergen powder) Disease Interactions

There are 3 disease interactions with Palforzia (peanut allergen powder):

Major

Peanut allergen extract (applies to Palforzia) anaphylaxis

Major Potential Hazard, Moderate plausibility. Applicable conditions: Cardiovascular Disease, Pulmonary Impairment

Peanut allergen extract should not be initiated in a patient who has had severe or life-threatening anaphylaxis within the previous 60 days. This agent may not be suitable for patients with certain medical conditions that may reduce the ability to survive anaphylaxis, including but not limited to markedly compromised lung function, severe mast cell disorder, or cardiovascular disease. Exercise care in these patients.

Major

Peanut allergen extract (applies to Palforzia) asthma

Major Potential Hazard, Moderate plausibility.

Peanut allergen extract is contraindicated in patients with uncontrolled asthma. Patients should have their asthma under control prior to initiation of therapy. It is recommended to temporarily withhold treatment in the event of an acute asthma exacerbation. Following resolution of the exacerbation, resumption should be undertaken cautiously. Re-evaluate patients who have recurrent asthma exacerbations and consider discontinuation of treatment. This agent has not been studied in subjects with severe asthma, persistently uncontrolled asthma, or patients on long-term systemic corticosteroid therapy.

Major

Peanut allergen extract (applies to Palforzia) eosinophilic disorder

Major Potential Hazard, Moderate plausibility. Applicable conditions: Esophagitis

Peanut allergen extract is contraindicated in patients with history of eosinophilic esophagitis and other eosinophilic gastrointestinal disease.

Palforzia (peanut allergen powder) drug interactions

There are 83 drug interactions with Palforzia (peanut allergen powder)

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.